| Issue Date | Title | Author(s) | Relation | scopus | WOS | Fulltext/Archive link |
| 2010 | A bioluminescent method for measuring thymidylate kinase activity suitable for high-throughput screening of inhibitor. | Hu, CM; Chang, ZF | ANALYTICAL CHEMISTRY 398(2),269-71 | | | |
| 2013 | A biomimetic nanosponge that absorbs pore-forming toxins. | Hu, CM; Fang, RH; Copp, J; Luk, BT; Zhang, L | Nature nanotechnology 8(5), 336-340 | | | |
| 2013 | A novel small molecule RAD51 inactivator overcomes imatinib-resistance in chronic myeloid leukaemia. | Zhu, J; Zhou, L; Wu, G; Konig, H; Lin, X; Li, G; Qiu, XL; Chen, CF; Hu, CM; Goldblatt, E; Bhatia, R; Chamberlin, AR; Chen, PL; Lee, WH | EMBO Molecular Medicine 5(3):353-65 | | | |
| 2010 | An electrophoretic method for the detection of chymotrypsin and trypsin activity directly in whole blood. | Lefkowitz, RB; Marciniak, JY; Hu, CM; Schmid-Schonbein, GW; Heller, MJ | Electrophoresis 31(2), 403-410 | | | |
| 2014 | Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. | Fang, RH; Hu, CM; Luk, BT; Gao, W; Copp, JA; Tai, Y; O’Connor, DE; Zhang, L | Nano letters 14(4), 2181-2188 | | | |
| 2018 | Cellular 5-hydroxylmethylcytosine content determines tumorigenic potential and prognosis of pancreatic ductal adenocarcinoma | Chen, YL; Hu, CM; Hsu, JT; Chang, CC; Huang, TY; Chiang, PH; Chen, WY; Chang, YT; Chang, MC; Tien, YW; Lee, EY; Jeng, YM; Lee, WH | American journal of cancer research 8(12), 2548-2563 | | | |
| 2014 | Clearance of pathological antibodies using biomimetic nanoparticles. | Copp, JA; Fang, RH; Luk, BT; Hu, CM; Gao, W; Zhang, K; Zhang, L | Proceedings of the National Academy of Sciences of the United States of America 111(37), 13481-13486 | | | |
| 2010 | Combinatorial drug conjugation enables nanoparticle dual-drug delivery. | Aryal, S; Hu, CM; Zhang, L | Small 6(13), 1442-1448 | | | |
| 2013 | Complementary interhelical interactions between three buried Glu-Lys pairs within three heptad repeats are essential for Hec1-Nuf2 heterodimerization and mitotic progression. | Ngo, B; Hu, CM; Guo, XE; Ngo, B; Wei, R; Zhu, J; Lee, WH | JOURNAL OF BIOLOGICAL CHEMISTRY 288 (48):34403-13. | | | |
| 2005 | Control of dTTP pool size by anaphase promoting complex/cyclosome is essential for the maintenance of genetic stability. | Ke, PY; Kuo, YY; Hu, CM; Chang, ZF | GENES & DEVELOPMENT 19(16),1920-33 | | | |
| 2015 | Detoxification of Organophosphate Poisoning Using Nanoparticle Bioscavengers. | Pang, Z; Hu, CM; Fang, RH; Luk, BT; Gao, W; Wang, F; Chuluun, E; Angsantikul, P; Thamphiwatana, S; Lu, W; Jiang, X; Zhang, L | ACS nano 9(6), 6450-6458 | | | |
| 2010 | Development of nanoparticles for antimicrobial drug delivery. | Zhang, L; Pornpattananangku, D; Hu, CM; Huang, CM | Current medicinal chemistry 17(6), 585-594 | | | |
| 2016 | Effect of the lipid II sugar moiety on bacterial transglycosylase: the 4-hydroxy epimer of lipid II is a TGase inhibitor. | Chen, KT; Lin, CK; Guo, CW; Chang, YF; Hu, CM; Lin, HH; Lai, Y; Cheng, TR; Cheng, WC | Chemical communications (Cambridge, England) 53(4):771-774 | | | |
| 2015 | Engineered nanoparticles mimicking cell membranes for toxin neutralization. | Fang, RH; Luk, BT; Hu, CM; Zhang, L | Advanced drug delivery reviews 90, 69-80 | | | |
| 2011 | Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform. | Hu, CM; Zhang, L; Aryal, S; Cheung, C; Fang, RH; Zhang, L | Proceedings of the National Academy of Sciences of the United States of America 108(27), 10980-10985 | | | |
| 2013 | Erythrocyte membrane-cloaked polymeric nanoparticles for controlled drug loading and release. | Aryal, S; Hu, CM; Fang, RH; Dehaini, D; Carpenter, C; Zhang, DE; Zhang, L | Nanomedicine 8(8), 1271-1280 | | | |
| 2012 | Erythrocyte-inspired delivery systems. | Hu, CM; Fang, RH; Zhang, L | Advanced healthcare materials 1(5), 537-547 | | | |
| 2005 | Establishment of Zebrafish as a Model Animal for Studying Human Disease: Construction of Diseaase - Digital Differential Display (D4) Database | Hu, CM; Hsiao, CD; Chen, YC; Lin, WD; Ho, JM; Hwang, PP | | | | |
| 2010 | Half-antibody functionalized lipid-polymer hybrid nanoparticles for targeted drug delivery to carcinoembryonic antigen presenting pancreatic cancer cells. | Hu, CM; Kaushal, S; Tran Cao, HS; Aryal, S; Sartor, M; Esener, S; Bouvet, M; Zhang, L | Molecular pharmaceutics 7(3), 914-920 | | | |
| 2007 | Hiding human thymidine kinase 1 from APC/C- mediated destruction by thymidine binding. | Ke, PY; Hu, CM; Chang, YC; Chang, ZF | FASEB JOURNAL 21(4),1276-84 | | | |
